Immunization with a cannabinoid receptor type 1 peptide results in experimental allergic meningocerebellitis in the Lewis rat: a model for cell-mediated autoimmune neuropathology.
Immunization with a cannabinoid receptor type 1 peptide results in experimental allergic meningocerebellitis in the Lewis rat: a model for cell-mediated autoimmune neuropathology.
复制标题
使用 1 型大麻素受体肽进行免疫会导致 Lewis 大鼠实验性过敏性脑膜小脑炎:细胞介导的自身免疫神经病理学模型。
DOI:
10.1002/jnr.10424
复制
发表时间:
2002
影响因子:
4.2
通讯作者:
Herkenham,Miles
中科院分区:
文献类型:
--
作者:
Proescholdt,MargitG;Quigley,Laura;Martin,Roland;Herkenham,Miles
Neuronal elements are increasingly suggested as primary targets of an autoimmune attack in certain neurological and neuropsychiatric diseases. Type 1 cannabinoid receptors (CB1) were selected as autoimmune targets because they are predominantly expressed on neuronal surfaces in brain and display strikingly high protein levels in striatum, hippocampus, and cerebellum. Female Lewis rats were immunized with N‐terminally acetylated peptides (50 or 400 μg per rat) of the extracellular domains of the rat CB1 and killed at various time points. Subsequent evaluation using immunohistochemistry and in situ hybridization showed dense infiltration of immune cells exclusively within the cerebellum, peaking 12–16 days after immunization with the CB1 peptide containing amino acids 9–25. The infiltrates clustered in meninges and perivascular locations in molecular and granular cell layers and were also scattered throughout the CB1‐rich neuropil. They consisted primarily of CD4+and ED1+cells, suggestive of cell‐mediated autoimmune pathology. There were no inflammatory infiltrates elsewhere in the brain or spinal cord. The results show that neuronal elements, such as neuronal cell‐surface receptors, may be recognized as antigenic targets in a cell‐mediated autoimmune attack and, therefore, support the hypothesis of cell‐mediated antineuronal autoimmune pathology in certain brain disorders. Published 2002 Wiley‐Liss, Inc.